Overexpression cell line

×

Subscribe Us

By subscription, you consent to allow Ubigene Biosciences to store and process the information provided above to deliver the latest news, research spotlight, and promotions. You can unsubscribe from these communications at anytime.

Location: Home > Gene Editing Services > Stable Cell Lines > Overexpression cell line

Overexpression Cell Line

The overexpression cell line are important tools for studying gene functions, disease mechanisms, and drug effects. Increasing the expression level of specific genes is used to achieve the function enhancement of genes. In addition, it can also be used in complementation experiments to verify the phenotypic recovery after gene knockout.

The overexpression vector is transferred into the cells through lentiviral transduction or nucleofection. As per the optimal antibiotic screening concentration explored in advance, the cells would be screened until the control cells die out to obtain a positive cell line with gene stable expression. The EZ-OE™ technology developed by Ubigene is different from the traditional lentiviral method and transposon method. It can not only achieve genome site-specific integration and single copy, but also has low cost and fast turnaround!

About EZ-OE™ Technology
EZ-OE™ is a genome engineering technology independently developed by Ubigene, which can achieve precise integration and stable expression of exogenous DNA safely and efficiently without the need for viruses. This technology provides safe, stable, and high-expression cell lines for scientific research and industrial clients, accelerating the process of gene function research, protein expression optimization, and candidate drug screening and evaluation.
Site-specific integration
Using advanced transposon system, the gene expression cassette is integrated at a specific site in the genome without the need for a virus, achieving high-level expression.
Single copy
Unique cell screening technology enables the gains of monoclonal-like stable cell lines with single copy, consistent genotype, and stable expression.

Service Details

Expression Stable Cell Line Service Details
Cell typeVarious types of cells including tumor cell lines, immortalized cell lines, IPS/ES cell lines
DeliverablesCell pool/Single-cell clone
Turnaround/Price  Please inquire

300+Successful
Gene-editing Cell Line Types

Respiratory System
+
Human Lung Cancer Cell Line(A549)Human Lung Cancer Cell Line(NCI-H1299)Human Lung Cancer Cell Line(NCI-H520)Human Lung Cancer Cell Line(SK-MES-1)Mouse Lewis lung carcinoma Cell Line(LLC)Human Bronchial Epithelial Cell Line(BEAS-2B)Human Lung Cancer Cell Line(HCC827)Porcine alveolar macrophage cell line(3D4/21)Human lung adenocarcinoma cell line(PC9)Human Lung Cancer Cell Line(NCI-H1650)Human Lung Cancer Cell Line(NCI-H727)Human lung adenocarcinoma cell line(NCI-H1975)Human lung cancer cell line(NCI-H292)Human Lung Cancer Cell Line(NCI-H23)Human Lung Cancer Cell Line(MSTO-211H)Human Lung Cancer Cell Line(NCI-H358)Human Non-small Cell Lung Carcinoma Cell Line(NCI-H460)Human lung adenocarcinoma cell line(Calu-3)Human Fetal Lung Fibroblast Cell Line(MRC-5)Human Highly Metastatic Lung Cancer Cell Line(95-D)Human Colon Carcinoma Cell Line(T84)MLE-12 Cell Complete Medium(MLE-12)Human Fetal Lung Fibroblast Cell Line(WI-38)Human Lung Cancer Cell Line(DMS114)Human lung adenocarcinoma cell line(NCI-H1373)Human Lung Cancer Cell Line(NCI-H1703)Human Lung Cancer Cell Line(DMS 53)Human Small Cell Lung Cancer Cell Line(NCI-H82 [H82])Human Small Cell Lung Cancer Cell Line(SHP-77)Human Lung Cancer Cell Line(NCI-H2170)
Circulatory System
+
Rat Cardiac Myocytes(H9c2(2-1))Mouse Myoblast Cell Line(C2C12)Human Cardiac Myocytes(AC16)Mouse Aortic Smooth Muscle Cell Line(MOVAS)
Endocrine System
+
Human Submandibular Gland Epidermoid Carcinoma Cell Line(A-253)Human Mammary Epithelial Cell Line(MCF 10A)Human Breast Cancer Cell Line(MDA-MB-231)Human Breast Cancer Cell Line(MCF7)Human Breast Cancer Cell Line(MDA-MB-415)Human Breast Cancer Cell Line(MDA-MB-468)Human Breast Epithelial Cell Line Integrating SV40 Gene(HBL-100)Human Prostate Cancer Cell Line(LNCaP Clone FGC)Human Prostate Cancer Cell Line(PC-3)Human Prostate Cancer Cell Line(22RV1)Human pancreatic cancer cell line(BxPC-3)Mouse Breast Cancer Cell Line(4T1)Mouse Acinar Pancreatic Cell Line(266-6)Human Breast Cancer Cell Line(JIMT-1)Mouse prostate cancer cell line(RM-1)Human Breast Cancer Cell Line(SK-BR-3)Human Breast Cancer Cell Line(HCC1806)Human Thyroid Normal Cell Line(Nthy-ori 3-1)Mouse pancreatic cancer cell line(Pan-02)Human Pancreatic Carcinoma Cell Line(SW1990)Human acute lymphoblastic leukemia cell line(MOLT4)Human Pancreatic Carcinoma Cell Line(Panc-1)Mouse Breast Adenocarcinoma Cell Line(E0771)Human Thyroid Squamous Cell Carcinoma Cell line(SW579)Human Breast Cancer Cell Line(HCC1143)Human breast cancer cell line(BT-549)Human acute lymphoblastic leukemia cell line(MT-4)Py230 Cell Line(Py230)Human Thyroid Cancer Cell Line(TPC-1)Human Prostate Cancer Cell Line(PC-3M)Human Burkitt's Lymphoma Cell Line(RAJI)Human Metastatic Pancreatic Adenocarcinoma Cell Line(AsPC-1)Human NK Leukemia Cell Line(YT)Human Prostate Cancer Cell Line(DU145)Mouse Mammary Epithelial Cell Line(HC11)Mouse Breast Cancer Cell Line(C127)Human Thyroid Normal Cell Line(Nthy-ori 3-1)Human Pancreatic Carcinoma Cell Line(MIA PaCa-2)Mouse Breast Cancer Cell Line(EMT6)Human Prostate Cancer Cell Line(VCaP)Human Breast Cancer Cell Line(SUM-149PT)Human breast ductal cancer cell Line(BT474)Human Pancreatic Carcinoma Cell Line(Capan2)
Brain and Nervous System
+
Rat Glioblastoma Cell Line(C6)Mouse Hippocampal Neuronal Cell Line(HT-22)Human Neuroblastoma Cell Line(SK-N-SH)Human Neuroblastoma Cell Line(SH-SY5Y)Human glioblastoma cell line(U-87 MG)Human glioblastoma cell line(U251MG)Mouse Anterior Parietal Bone Cell Line(MC3T3-E1 Subclone 14)Mouse microglia cell line(BV2)Human microglial clone 3 cell line(HMC3)Mouse neuroblastoma cell line(Neuro-2a)Human glioblastoma cell line(LN-229)Mouse Glioblastoma Cell Line(GL261)Human Glioblastoma Cell Line(T98G)Human Glioblastoma Cell Line(A-172)Human Neuroblastoma Cell Line(SK-N-BE(2))Human Brain Astrocytoma Cell Line(Hs 683)Rat Glioblastoma Cell Line(RG2)
Blood and lymphatic System
+
Mouse Hybridoma Cell Line(AE-1)Hybridoma (Anti-Cd3) Cell Line(OKT 3)Human Monocytic Cell Line(THP-1)Human Histiocytic Lymphoma Cell Line(U-937)Human T Lymphocyte Cell Line(Jurkat, Clone E6-1)Human Acute Lymphocyte Cell Line(OCI-Aml-3)Human myelogenous Leukemia Cell Line(K-562)Mouse Macrophage Cell Line(RAW 264.7)Human Acute Promyelocytic Leukemia Cell Line(HL-60)Human B Lymphoma Cell Line(U-2932)Mouse B Lymphoma Cell Line(A20)Human Myelomonocytic Leukemia Cell Line(MV4-11)Human B Lymphoma Cell Line(SU-DHL-4)Human Acute Myeloid Leukemia Cell Line(KG-1a)Human Erythroleukemia Cell Line(HEL)Mouse Pro B Cell Line(BAF3)Human acute promyelocytic leukemia cell line(NB4)Human T-lymphocyte Cell Line(Hut-78)Human B Lymphocytes Cell Line(GM12878)Mouse Lymphoma Cell Line(EL4)Mouse Macrophage Cell Line(Ana-1)Human Erythroleukemia Cell Line(TF-1)Human Lymphoma Cell Line(BC-3)Human Multiple Myeloma Peripheral Blood B Lymphocytes(RPMI 8226)Human Burkitt's Lymphoma B Lymphocytes(Ramos)Human B lymphoma cell line(SU-DHL-6)Human Acute Lymphoblastic Leukemia Cell Line (Non-B Non-T)(Reh)Human?Acute?Lymphocyte?Cell?Line(Kasumi-1)Human Mantle Cell Lymphoma Cell Line(JeKo-1)Human peripheral blood mantle lymphoma Cell Line(Mino)Human Acute Myeloid Leukemia Cell Line(MOLM13)Human B lymphocytic leukaemia Cell Line(NALM-6)Human B lymphoma cell line(SU-DHL-8)
Urinary System
+
African green monkey kidney cell(Vero)African green monkey kidney cell(VERO C1008 (E6))Dog Kidney Cell Line(MDCK(NBL-2))Human Embryonic Kidney Cell Line(293T)Human Embryonic Kidney Cell Line(293T)Human Embryonic Kidney Cell Line(HEK293)Rat adrenal pheochromocytoma cell line(Low differentiation)(PC-12)Human Bladder Transitional Cell Carcinoma Cell Line(T24)Human bladder carcinoma cell line(5637)Mouse Bladder Cancer Cell(MB-49)Human renal cell carcinoma cell line(786-0)Human renal cell carcinoma cell line(MS751)Mouse podocyte cell line(MPC-5)Pig Kidney Cell  line(PK-15)Human Embryonic Kidney Cell Line(2V6.11)Human Bladder Transitional Cell Carcinoma Cell Line(SW780)Transformed (SV40) African Green Monkey Kidney Cell Line(COS-1)Transformed (SV40) African Green Monkey Kidney Cell Line(COS-7)Rat Kidney Cell Line(NRK-52E)Mouse Renal Adenocarcinoma Cell Line(RenCa)Bovine Kidney (MDBK) Cell Line(MDBK (NBL-1))Hamster Kidney Fibroblasts(BHK-21)Human Renal Proximal Tubular Epithelial Cell Line(HK-2)Human Urinary Bladder Squamous Cell Carcinoma Cell Line(SCaBER)Mouse Renal Adenocarcinoma Cell Line(RAG)Mouse Bladder Cancer Cell(MBT-2)Human renal carcinoma cell line(OS-RC-2)
Digestive System
+
Human Gallbladder Carcinoma Cell Line(GBC-SD)Human Hepatoma Cell Line(Hep G2)Human Hepatoma Cell Line(SNU-387)Human Hepatoma Cell Line(HuH-7)Human Hepatoma Cell Line(SK-HEP-1)Human Hepatoma Cell Line(Hep 3B)Human Normal Hepatocytes Cell line(L-02)Human Colon Cancer Cell Line(HCT 116)Human Colon Cancer Cell Line(HT-29)Human colorectal adenocarcinoma cell line(RKO)Human colorectal adenocarcinoma cell line(Caco-2)Human Esophageal Squamous Carcinoma Cell Line(KYSE-150)Human gastric cancer cell line(AGS)Mouse Hepatocarcinoma Cell Line(Hepa 1-6)Murine colorectal carcinoma cell line(CT26.WT)Murine colorectal carcinoma cell line(MC38)Human Esophageal Squamous Carcinoma Cell Line(KYSE-30)Mouse Hepatocarcinoma Cell Line(H22)Human Gastric Cancer Cell Line(NCI-N87)Human colorectal adenocarcinoma cell line(SW480)Human Hepatoma Cell Line(SMMC-7721)Porcine intestinal epithelial cell line(IPEC-J2)Human Gastric Cancer Cell Line(HGC-27)Human Gastric Cancer Cell Line(MGC-803)Human renal carcinoma cell line(ACHN)Human colorectal adenocarcinoma cell line(LS 174T)Immortalized Human Hepatic Cell Line(C3A)Human Hepatoma Cell Line(PLC/PRF/5)Human colorectal adenocarcinoma cell line(SW 48)Human colorectal adenocarcinoma cell line(SW948)Human colorectal adenocarcinoma cell line(NCI-H716)Mouse hepatocyte cell line(AML12)Human Gastric Cancer Cell Line(SGC-7901)Human Ileocecal Cancer Cell Line(HRT-18)Human Colon Cancer Cell Line(LoVo)Human Hepatoma Cell Line(MHCC97-H)Human Gastric Cancer Cell Line(MKN-45)Human Colon Cancer Cell Line(COLO 205)Rat Liver Cell Line(BRL)Mouse Gastric Cancer Cell Line(MFC)Human Colon Cancer Cell Line(SW620)Human Hepatoma Cell Line(Li-7)Mouse Ascites Sarcoma Cell Line(S180)Rat Liver Cell Line(BRL-3A)Human Colon Cancer Cell Line(HCT-15)Human Gastric Cancer Cell Line(KATO III)Human colorectal adenocarcinoma cell line(SW1463)Human Gastric Cancer Cell Line(SNU-5)Human colorectal adenocarcinoma cell line(SW1116 [SW 1116, SW-1116])Human Hepatic Stellate Cell Line(LX-2)Human Hepatoma Cell Line(HCCLM3)
Skeleton, Articulus, Soft Tissue, Derma System
+
Human Umbilical Vein Cell Line(EA.hy926)Mouse Lewis lung carcinoma Cell Line(U-2 OS)Human Osteosarcoma Cell Line(Saos-2)Human skin squamous carcinoma cell line(A-431)Murine melanoma cell line(B16-F10)Human malignant melanoma cell line(A-375)Human Skin Fibroblast Cell Line(BJ)Mouse Fibroblast Cell Line(L-929)Mouse Lewis lung carcinoma Cell Line(SW 1353)Human fibrosarcoma cell line(HT-1080)Rat osteosarcoma cell line(UMR-106)Human Immortalized Keratinocytes Cell line(HaCaT)Chicken Fibroblast Cell line(DF1)Human Multiple Myeloma Cell Line(MM.1S)Human Corneal Epithelial Cell Line(HCE-T)(HCE-T)Immortalized Human Lens Epithelial Adherent Cell Line(SRA01/04)Mouse Lewis lung carcinoma Cell Line(MG-63)Mouse Osteosarcoma Cell Line(K7M2-WT)Mouse Lewis lung carcinoma Cell Line(143B)Mouse Subcutaneous Connective Tissue Cell Line(A9)Mouse squamous carcinoma cell line(SCC-7)Human Choriocarcinoma Cell Line(JAR)Human bone osteosarcoma epithelial cell line(KHOS-240S)Mouse Chondrogenic Cell Line(ATDC5)
Ocular, Otolaryngologic and Oral System
+
Human Pharyngeal Carcinoma Cell Line (Pleural Effusion Metastasis)(Detroit 562)Human retinal pigment epithelial cell line(ARPE-19)Human Nasopharyngeal Carcinoma Cell Line(CNE1)Human oral squamous carcinoma cell line(HSC3)Human nasopharyngeal carcinoma cell line(HK-1)Human oral squamous carcinoma cell line(CAL-27)Mouse Cochlear Hair Cell Line(HEI-OC1)Human Retinoblastoma Cell Line(Y79)Human Tongue Squamous Carcinoma Cell Line(SCC-9)Human Pharyngeal Squamous Cell Carcinoma Cell Line(FaDu)
Reproductive System
+
Human Amniotic Cell Line(WISH)Human Highly Metastatic Ovarian Cancer Cell Line(HO-8910PM)African green monkey kidney cell Line(Marc-145)Human Cervical Carcinoma Cell Line(Hela)Human ovarian cancer cell line(OVCAR-3)Human Ovarian Adenocarcinoma Cell Line(Caov-3)Mouse Embryonic Fibroblasts(NIH/3T3)Mouse Fibroblast Cell Line(TM3)Human Villous Trophoblast(HTR-8/SVneo)Human Ovarian Granulosa Cell Line(KGN)Chinese Hamster Ovary Cell Line(CHO-K1)Human Endometrial Adenocarcinoma Cell Line(MFE-280)Mouse ovarian epithelial cancer Cell(ID8)Human endometrial adenocarcinoma cell(HEC-1-B)Human Endometrial Carcinoma Cell Line (ISHIKAWA)Human Cervical Carcinoma Cell Line(C-33 A)Human Cervical Carcinoma Cell Line(Ca Ski)Human Endometrial Carcinoma Cell Line (KLE)Mouse Teratocarcinoma Cell Line(P19)Human Ovarian Clear Cell Carcinoma Cell Line(ES-2)Human Endometrial Adenocarcinoma Cell Line(AN3 CA)Human Cervical Carcinoma Cell Line(hela 229)Human Ovarian Adenocarcinoma Cell Line(SK-OV-3)Human Choriocarcinoma Cell Line(Bewo)
Stem Cell
+
Stem Cell(H9)Human Embryonic Stem Cell(H1)Induced Pluripotent Stem Cell(ipsc)
Work Flow and Validation
Overexpression Cell Line Work Flow and Validation Overexpression Cell Line Work Flow and Validation
Available YOE plasmids:
YOE seriesVectorReporter gene; Selection marker
Lentiviral YOE plasmid YOE-LV001 EGFP/Puro
YOE-LV002 mCherry/Puro
YOE-LV003 EGFP/Neo
YOE-LV004 mCherry/Neo
YOE-LV005 Puro
YOE-LV006 EGFP
YOE-LV007 mCherry
YOE-LV008 Luciferase/Puro
EZ-editor™ Stable Cell Line Bank (In-stock)
Cas9 Stable Cell Lines
100+
Easy to use, Enables high knockout efficiency
Luciferase Stable Cell Lines
100+
Stable expression, low passages, high activity
EGFP Stable Cell Lines
50+
Stable expression, low passages, high activity
Selected Cited Papers
Overexpressing PRDX5 protein on LNCaP cell line
IF=15.1
Advanced Science
Overexpressing PRDX5 protein on LNCaP cell line
IF=15.1 Advanced Science
Abstract:
Recently, Dr. Rong Wang, from a research group led by Professor Yong Q Chen from Jiangnan University, China, published a research paper titled "Identification of PRDX5 as A Target for The Treatment of Castration-Resistant Prostate Cancer" on Advanced Science (IF=15.1). In this study, CRISPR-Cas9 PRDX5 knockout 22Rv1 cells and LNCaP cells with lentiviral overexpression of PRDX5 gene constructed by Ubigene were used to discover the new mechanism of PRDX5 affecting the progress of castration-resistant prostate cancer (CRPC) by regulating redox , and to explore the therapeutic effect of its targeting new small molecule drug Polaprezinc (POL) on CRPC in cells, animals and clinic. It provides a new target for clinical drug resistance of prostate cancer, and provides the possibility of new drugs combined with antiandrogen for patients with CRPC, so as to prolong the life cycle of patients with CRPC. View details>>
Key role of PRDX5 in AR inhibitor resistance and CRPC development
Key role of PRDX5 in AR inhibitor resistance and CRPC development
HeLa and HepG2 cell lines overexpressing ACE2
IF=8.2
Acta Pharmacologica Sinica
HeLa and HepG2 cell lines overexpressing ACE2
IF=8.2 Acta Pharmacologica Sinica
SARS-CoV-2 receptor binding domain radio-probe: a non-invasive approach for angiotensin-converting enzyme 2 mapping in mice
Published by Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China
Abstract:
In order to verify the affinity of angiotensin-converting enzyme ACE at the cellular level, the author successfully constructed 124I-RBD as a novel targeted molecular probe for COVID-19 for the first time with the help of HeLa and HepG2 cell lines overexpressing ACE2 provided by Ubigene and confirmed that 124I-RBD antibody has high affinity and selectivity for ACE2 through the binding experiment of RBD and human ACE2 receptor. View details>>
PET imaging of tumor models
PET imaging of tumor models
MSCs overexpression Tandab
IF=7.5
Stem Cell Research & Therapy
MSCs overexpression Tandab
IF=7.5 Stem Cell Research & Therapy
Construction of tandem diabody (IL-6/CD20)-secreting human umbilical cord mesenchymal stem cells and its experimental treatment on diffuse large B cell lymphoma
Published by The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Abstract:
This paper uses the Tandab overexpression stable cell line constructed by Ubigene and empty control stable cell line to study the therapeutic effect of Tandab overexpressing MSCs on diffuse large B-cell lymphoma (DLBCL). The results showed that Tandab(IL-6/CD20) protein could target CD20-positive DLBCL cells, inhibit IL-6-related signaling pathway, and eliminate the promoting effect of IL-6 on lymphoma cells, which provided a potential strategy for the treatment of DLBCL. View details>>
UCMSCs-Tandab(IL-6/CD20) inhibits the proliferation of SU-DHL-2/4
UCMSCs-Tandab(IL-6/CD20) inhibits the proliferation of SU-DHL-2/4
CT26 cells overexpressing luciferase
IF=5.2
Cancers
CT26 cells overexpressing luciferase
IF=5.2 Cancers
Gas Flow Shaping via Novel Modular Nozzle System (MoNoS) Augments kINPen-Mediated Toxicity and Immunogenicity in Tumor Organoids
Published by Greifswald University Medical Center and the Leibniz Institute for Plasma Science and Technology in Germany
Abstract:
Gas plasma is a new tool for cancer treatment, among which the cold plasma jet kINPen has the most significant function. This study developed the MoNoS system to improve the flow properties of kiNPen using mouse CT26 cells overexpressing luciferase provided by Ubigene as research materials. Research has found that under clinically relevant raw gas flux, kINPen therapy adapted to MoNoS can significantly reduce cancer cell growth and increase tumor immunogenicity, while verifying its safety. This result further demonstrates the feasibility of using flow-shaping adapters (such as MoNoS) to enhance gas plasma jet therapy for cancer. View details>>
The antitumor activity of MoNos-assisted gas plasma therapy at high gas flow rate was superior to that of typical kINPen therapy
The antitumor activity of MoNos-assisted gas plasma therapy at high gas flow rate was superior to that of typical kINPen therapy

Contact us

* How would you like us to contact you?
How did you hear about us:
 Google search
 Email
 Publication
 Recommendations from others
 Social media
 Others
Our Solution Specialists will contact you within 2 business days. Of course, you can also tell us when you would like to be contacted:

Our Solution Specialists will contact you as soon as possible!


Contact us